{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:38:31Z","timestamp":1793036311627,"version":"4.5.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670855"],"award-info":[{"award-number":["81670855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Science and Development Key Program","award":["201804020010"],"award-info":[{"award-number":["201804020010"]}]},{"name":"China Postdoctoral Science Foundation grant","award":["2018M633240"],"award-info":[{"award-number":["2018M633240"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.phrs.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T11:37:16Z","timestamp":1551872236000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Novel function of VEGF-B as an antioxidant and therapeutic implications"],"prefix":"10.1016","volume":"143","author":[{"given":"Rongyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianchai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuri","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2019.03.002_bib0005","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1073\/pnas.93.6.2576","article-title":"Vascular endothelial growth factor B, a novel growth factor for endothelial cells","volume":"93","author":"Olofsson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.002_bib0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.molmed.2011.11.006","article-title":"Complicated life, complicated VEGF-B","volume":"18","author":"Li","year":"2012","journal-title":"Trends Mol. Med."},{"issue":"15","key":"10.1016\/j.phrs.2019.03.002_bib0015","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1073\/pnas.0813061106","article-title":"VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0020","first-page":"913","article-title":"VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats","volume":"118","author":"Li","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.phrs.2019.03.002_bib0025","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/ATVBAHA.107.158725","article-title":"Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium","volume":"28","author":"Li","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7420","key":"10.1016\/j.phrs.2019.03.002_bib0030","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature11464","article-title":"Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes","volume":"490","author":"Hagberg","year":"2012","journal-title":"Nature"},{"issue":"7290","key":"10.1016\/j.phrs.2019.03.002_bib0035","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature08945","article-title":"Vascular endothelial growth factor B controls endothelial fatty acid uptake","volume":"464","author":"Hagberg","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.002_bib0040","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cmet.2016.03.004","article-title":"VEGFB\/VEGFR1-induced expansion of adipose vasculature counteracts obesity and related metabolic complications","volume":"23","author":"Robciuc","year":"2016","journal-title":"Cell Metab."},{"issue":"41","key":"10.1016\/j.phrs.2019.03.002_bib0045","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1073\/pnas.1801379115","article-title":"VEGF-B is a potent antioxidant","volume":"115","author":"Arjunan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.002_bib0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1101\/gr.6.2.124","article-title":"Cloning and characterization of a novel human gene related to vascular endothelial growth factor","volume":"6","author":"Grimmond","year":"1996","journal-title":"Genome Res."},{"issue":"31","key":"10.1016\/j.phrs.2019.03.002_bib0055","doi-asserted-by":"crossref","first-page":"23779","DOI":"10.1074\/jbc.M110.130658","article-title":"Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity","volume":"285","author":"Iyer","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"282","key":"10.1016\/j.phrs.2019.03.002_bib0060","doi-asserted-by":"crossref","first-page":"ra52","DOI":"10.1126\/scisignal.2003905","article-title":"The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands","volume":"6","author":"Anisimov","year":"2013","journal-title":"Sci. Signal."},{"issue":"20","key":"10.1016\/j.phrs.2019.03.002_bib0065","doi-asserted-by":"crossref","first-page":"11709","DOI":"10.1073\/pnas.95.20.11709","article-title":"Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells","volume":"95","author":"Olofsson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"30","key":"10.1016\/j.phrs.2019.03.002_bib0070","doi-asserted-by":"crossref","first-page":"21217","DOI":"10.1074\/jbc.274.30.21217","article-title":"Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1","volume":"274","author":"Makinen","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.phrs.2019.03.002_bib0075","doi-asserted-by":"crossref","first-page":"19310","DOI":"10.1074\/jbc.271.32.19310","article-title":"Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform","volume":"271","author":"Olofsson","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/08977190109001075","article-title":"Isoform-specific expression of VEGF-B in normal tissues and tumors","volume":"19","author":"Li","year":"2001","journal-title":"Growth Factors"},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0085","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1152\/physrev.00028.2013","article-title":"Vascular endothelial growth factor-B in physiology and disease","volume":"94","author":"Bry","year":"2014","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jso.21095","article-title":"Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters","volume":"98","author":"Kanda","year":"2008","journal-title":"J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.002_bib0095","first-page":"519","article-title":"Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family","volume":"5","author":"Shibuya","year":"1990","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.phrs.2019.03.002_bib0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/01.RES.0000081594.21764.44","article-title":"Vascular endothelial growth factor-B promotes in vivo angiogenesis","volume":"93","author":"Silvestre","year":"2003","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.phrs.2019.03.002_bib0105","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/CIRCRESAHA.110.220855","article-title":"Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy","volume":"106","author":"Pepe","year":"2010","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.002_bib0110","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.108.816454","article-title":"Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms","volume":"119","author":"Lahteenvuo","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2019.03.002_bib0115","doi-asserted-by":"crossref","first-page":"40582","DOI":"10.1038\/srep40582","article-title":"VEGF-B promotes recovery of corneal innervations and trophic functions in diabetic mice","volume":"7","author":"Di","year":"2017","journal-title":"Sci. Rep."},{"issue":"48","key":"10.1016\/j.phrs.2019.03.002_bib0120","doi-asserted-by":"crossref","first-page":"17272","DOI":"10.1073\/pnas.1407227111","article-title":"VEGF-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions","volume":"111","author":"Guaiquil","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/emmm.201303147","article-title":"VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart","volume":"6","author":"Kivela","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"44","key":"10.1016\/j.phrs.2019.03.002_bib0130","doi-asserted-by":"crossref","first-page":"E5944","DOI":"10.1073\/pnas.1510245112","article-title":"VEGF-B-Neuropilin-1 signaling is spatiotemporally indispensable for vascular and neuronal development in zebrafish","volume":"112","author":"Jensen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.CIR.104.3.358","article-title":"Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect","volume":"104","author":"Aase","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.phrs.2019.03.002_bib0140","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1161\/01.RES.86.2.e29","article-title":"Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia","volume":"86","author":"Bellomo","year":"2000","journal-title":"Circ. Res."},{"issue":"17","key":"10.1016\/j.phrs.2019.03.002_bib0145","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.110.957332","article-title":"Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation","volume":"122","author":"Bry","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.phrs.2019.03.002_bib0150","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1161\/01.RES.0000182631.33638.77","article-title":"Transgenic overexpression of vascular endothelial growth factor-B isoforms by endothelial cells potentiates postnatal vessel growth in vivo and in vitro","volume":"97","author":"Mould","year":"2005","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1442-9071.2003.00602.x","article-title":"Vascular endothelial growth factor-B and retinal vascular development in the mouse","volume":"31","author":"Reichelt","year":"2003","journal-title":"Clin. Experiment. Ophthalmol."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0160","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jcb.21124","article-title":"Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis","volume":"100","author":"Brkovic","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.phrs.2019.03.002_bib0165","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/00007890-200206150-00003","article-title":"VEGF-A and -C but not -B mediate increased vascular permeability in preserved lung grafts","volume":"73","author":"Abraham","year":"2002","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.phrs.2019.03.002_bib0170","doi-asserted-by":"crossref","first-page":"L926","DOI":"10.1152\/ajplung.00247.2002","article-title":"Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension","volume":"284","author":"Louzier","year":"2003","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"10","key":"10.1016\/j.phrs.2019.03.002_bib0175","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","article-title":"VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses","volume":"92","author":"Rissanen","year":"2003","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.002_bib0180","first-page":"1029","article-title":"Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis","volume":"146","author":"Dvorak","year":"1995","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.002_bib0185","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.phrs.2019.03.002_bib0190","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1093\/emboj\/16.13.3898","article-title":"Proteolytic processing regulates receptor specificity and activity of VEGF-C","volume":"16","author":"Joukov","year":"1997","journal-title":"EMBO J."},{"issue":"47","key":"10.1016\/j.phrs.2019.03.002_bib0195","doi-asserted-by":"crossref","first-page":"31273","DOI":"10.1074\/jbc.273.47.31273","article-title":"A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR\/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain","volume":"273","author":"Ogawa","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0200","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0891-5849(99)00242-7","article-title":"Oxidative stress and gene regulation","volume":"28","author":"Allen","year":"2000","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.002_bib0205","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00004872-200018060-00002","article-title":"Role of oxidative stress in cardiovascular diseases","volume":"18","author":"Dhalla","year":"2000","journal-title":"J. Hypertens."},{"issue":"10","key":"10.1016\/j.phrs.2019.03.002_bib0210","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ. Res."},{"issue":"24","key":"10.1016\/j.phrs.2019.03.002_bib0215","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1042\/CS20171246","article-title":"Oxidative stress and reactive oxygen species: a review of their role in ocular disease","volume":"131","author":"Ung","year":"2017","journal-title":"Clin. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2019.03.002_bib0220","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/ijc.23192","article-title":"Chronic inflammation and oxidative stress in human carcinogenesis","volume":"121","author":"Federico","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.phrs.2019.03.002_bib0225","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cmet.2012.10.018","article-title":"A heme-sensing mechanism in the translational regulation of mitochondrial cytochrome c oxidase biogenesis","volume":"16","author":"Soto","year":"2012","journal-title":"Cell Metab."},{"issue":"9549","key":"10.1016\/j.phrs.2019.03.002_bib0230","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2019.03.002_bib0235","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-1-40","article-title":"Retinitis pigmentosa","volume":"1","author":"Hamel","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.phrs.2019.03.002_bib0240","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrg2717","article-title":"Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait","volume":"11","author":"Wright","year":"2010","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.002_bib0245","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.mam.2012.03.006","article-title":"How does the macula protect itself from oxidative stress?","volume":"33","author":"Handa","year":"2012","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.phrs.2019.03.002_bib0250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.preteyeres.2017.08.004","article-title":"The mechanism of cone cell death in Retinitis Pigmentosa","volume":"62","author":"Campochiaro","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0255","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1471-4159.2009.06195.x","article-title":"NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa","volume":"110","author":"Usui","year":"2009","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.phrs.2019.03.002_bib0260","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/ars.2015.6327","article-title":"Is There Excess Oxidative Stress and Damage in Eyes of Patients with Retinitis Pigmentosa?","volume":"23","author":"Campochiaro","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0265","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/jcp.21152","article-title":"Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa","volume":"213","author":"Komeima","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.phrs.2019.03.002_bib0270","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.molmed.2016.06.009","article-title":"A revised hemodynamic theory of age-related macular degeneration","volume":"22","author":"Gelfand","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.002_bib0275","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nri3459","article-title":"Immunology of age-related macular degeneration","volume":"13","author":"Ambati","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.002_bib0280","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.mam.2012.03.009","article-title":"Consequences of oxidative stress in age-related macular degeneration","volume":"33","author":"Jarrett","year":"2012","journal-title":"Mol. Aspects Med."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.002_bib0285","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nm1709","article-title":"Oxidative damage-induced inflammation initiates age-related macular degeneration","volume":"14","author":"Hollyfield","year":"2008","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.002_bib0290","first-page":"351","article-title":"RAGE on the Toll Road?","volume":"3","author":"Lin","year":"2006","journal-title":"Cell. Mol. Immunol."},{"issue":"30","key":"10.1016\/j.phrs.2019.03.002_bib0295","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.0602131103","article-title":"Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration","volume":"103","author":"Imamura","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.phrs.2019.03.002_bib0300","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1167\/iovs.07-0432","article-title":"SOD2 knockdown mouse model of early AMD","volume":"48","author":"Justilien","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.002_bib0305","doi-asserted-by":"crossref","first-page":"e19456","DOI":"10.1371\/journal.pone.0019456","article-title":"Age-related retinopathy in NRF2-deficient mice","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.03.002_bib0310","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fphar.2018.01280","article-title":"Oxidative stress in age-related macular degeneration: Nrf2 as therapeutic target","volume":"9","author":"Bellezza","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0315","first-page":"28","article-title":"Age-related macular degeneration and antioxidant vitamins: recent findings","volume":"13","author":"Johnson","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"24","key":"10.1016\/j.phrs.2019.03.002_bib0320","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1001\/jama.294.24.3101","article-title":"Dietary intake of antioxidants and risk of age-related macular degeneration","volume":"294","author":"van Leeuwen","year":"2005","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.phrs.2019.03.002_bib0325","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","journal-title":"Arch. Ophthalmol."},{"issue":"10","key":"10.1016\/j.phrs.2019.03.002_bib0330","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archopht.119.10.1439","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e and beta carotene for age-related cataract and vision loss: AREDS report no. 9","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","journal-title":"Arch. Ophthalmol."},{"issue":"7","key":"10.1016\/j.phrs.2019.03.002_bib0335","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jamaophthalmol.2013.4412","article-title":"Lutein\/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4","volume":"131","author":"The Age-Related Eye Disease Study 2 Research Group","year":"2013","journal-title":"JAMA Ophthalmol."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0340","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3945\/an.116.013177","article-title":"The age-related eye disease 2 study: micronutrients in the treatment of macular degeneration","volume":"8","author":"Gorusupudi","year":"2017","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.phrs.2019.03.002_bib0345","doi-asserted-by":"crossref","first-page":"26059","DOI":"10.1038\/srep26059","article-title":"VEGF-B inhibits hyperglycemia- and Macugen-induced retinal apoptosis","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.002_bib0350","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI2425","article-title":"Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin","volume":"102","author":"Barber","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2019.03.002_bib0355","doi-asserted-by":"crossref","first-page":"3420187","DOI":"10.1155\/2018\/3420187","article-title":"The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy","volume":"2018","author":"Wu","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1008","key":"10.1016\/j.phrs.2019.03.002_bib0360","article-title":"Autophagy Dysfunction and Oxidative Stress, Two Related Mechanisms Implicated in Retinitis Pigmentosa","volume":"9","author":"Moreno","year":"2018","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0365","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11095-008-9723-z","article-title":"Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K\/AKT signaling pathways","volume":"26","author":"Roy","year":"2009","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.002_bib0370","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/nu8040200","article-title":"Resveratrol and ophthalmic diseases","volume":"8","author":"Abu-Amero","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2019.03.002_bib0375","doi-asserted-by":"crossref","DOI":"10.4137\/DTI.S9442","article-title":"Resveratrol targeting of carcinogen-induced brain endothelial cell inflammation biomarkers MMP-9 and COX-2 is Sirt1-Independent","volume":"6","author":"Annabi","year":"2012","journal-title":"Drug Target Insights"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0380","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1111\/j.1755-3768.2011.02243.x","article-title":"Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas","volume":"90","author":"Kim","year":"2012","journal-title":"Acta Ophthalmol."},{"issue":"14","key":"10.1016\/j.phrs.2019.03.002_bib0385","doi-asserted-by":"crossref","first-page":"8246","DOI":"10.1021\/jf1012067","article-title":"trans-Resveratrol Inhibits Hyperglycemia-Induced Inflammation and Connexin Downregulation in Retinal Pigment Epithelial Cells","volume":"58","author":"Losso","year":"2010","journal-title":"J. Agric. Food Chem."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.002_bib0390","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00417-014-2604-8","article-title":"Resveratrol and the eye: activity and molecular mechanisms","volume":"252","author":"Bola","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.002_bib0395","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s001250050726","article-title":"Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine","volume":"40","author":"Hammes","year":"1997","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.phrs.2019.03.002_bib0400","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1517\/13543784.10.9.1665","article-title":"Therapeutic potential of anti-oxidants and diabetic retinopathy","volume":"10","author":"Kowluru","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"8","key":"10.1016\/j.phrs.2019.03.002_bib0405","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.50.8.1938","article-title":"Abnormalities of retinal metabolism in diabetes and experimental galactosemia, VII. Effect of Long-Term Administration of Antioxidants on the Development of Retinopathy","volume":"50","author":"Kowluru","year":"2001","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.002_bib0410","first-page":"585","article-title":"Neuroprotection and regeneration in glaucoma","volume":"18","author":"Levin","year":"2005","journal-title":"Ophthalmol. Clin. North Am."},{"key":"10.1016\/j.phrs.2019.03.002_bib0415","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.arr.2016.05.012","article-title":"From DNA damage to functional changes of the trabecular meshwork in aging and glaucoma","volume":"29","author":"Sacc\u00e0","year":"2016","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.002_bib0420","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mrrev.2005.11.001","article-title":"The role of oxidative stress in glaucoma","volume":"612","author":"Izzotti","year":"2006","journal-title":"Mutat. Res."},{"issue":"9","key":"10.1016\/j.phrs.2019.03.002_bib0425","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1096\/fj.04-3313fje","article-title":"R.E. Rosenstein, Effect of glaucoma on the retinal glutamate\/glutamine cycle activity","volume":"19","author":"Moreno","year":"2005","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.002_bib0430","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.freeradbiomed.2004.06.001","article-title":"Retinal oxidative stress induced by high intraocular pressure","volume":"37","author":"Moreno","year":"2004","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0435","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2353\/ajpath.2006.050765","article-title":"Role of apoptosis signal-regulating kinase 1 in stress-induced neural cell apoptosis in vivo","volume":"168","author":"Harada","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2019.03.002_bib0440","series-title":"Progress in Brain Research","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0079-6123(08)01124-2","article-title":"Pathogenesis of ganglion \u201ccell death\u201d in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria","author":"Osborne","year":"2008"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.002_bib0445","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.exer.2011.05.008","article-title":"Manganese porphyrin reduces retinal injury induced by ocular hypertension in rats","volume":"93","author":"Dogan","year":"2011","journal-title":"Exp. Eye Res."},{"issue":"9","key":"10.1016\/j.phrs.2019.03.002_bib0450","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/IJG.0b013e31819c46b1","article-title":"Retinal oxidative stress induced by intraocular hypertension in rats may be ameliorated by brimonidine treatment and N-acetyl cysteine supplementation","volume":"18","author":"Ozdemir","year":"2009","journal-title":"J. Glaucoma"},{"issue":"8","key":"10.1016\/j.phrs.2019.03.002_bib0455","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s10571-012-9852-0","article-title":"N-acetylcysteine protects against hypoxia mimetic-induced autophagy by targeting the HIF-1\u03b1 pathway in retinal ganglion cells","volume":"32","author":"Yang","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5337","key":"10.1016\/j.phrs.2019.03.002_bib0460","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.278.5337.412","article-title":"Life and death of neurons in the aging brain","volume":"278","author":"Morrison","year":"1997","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.phrs.2019.03.002_bib0465","doi-asserted-by":"crossref","first-page":"13534","DOI":"10.1073\/pnas.93.24.13534","article-title":"Memory systems analyses of mnemonic disorders in aging and age-related diseases","volume":"93","author":"Gabrieli","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2019.03.002_bib0470","series-title":"Neurodegenerative Diseases","first-page":"278","article-title":"Oxidative stress in developmental brain disorders","author":"Hayashi","year":"2012"},{"issue":"5","key":"10.1016\/j.phrs.2019.03.002_bib0475","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.25071","article-title":"Age, vascular health, and Alzheimer disease biomarkers in an elderly sample","volume":"82","author":"Vemuri","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2019.03.002_bib0480","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nn.4489","article-title":"Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain","volume":"20","author":"Kisler","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.002_bib0485","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/jnc.14271","article-title":"White matter degeneration in vascular and other ageing-related dementias","volume":"144","author":"Hase","year":"2018","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.phrs.2019.03.002_bib0490","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","article-title":"Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis, Journal of Neurology","volume":"88","author":"Zou","year":"2017","journal-title":"Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2019.03.002_bib0495","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617734734","article-title":"Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis","volume":"11","author":"Dorst","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.phrs.2019.03.002_bib0500","first-page":"41","article-title":"Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS","volume":"9","author":"Carri","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2019.03.002_bib0505","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fncel.2014.00131","article-title":"The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis","volume":"8","author":"Pollari","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2019.03.002_bib0510","article-title":"Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs","author":"Jaiswal","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2019.03.002_bib0515","first-page":"61","article-title":"Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis","volume":"7","author":"Hinchcliffe","year":"2017","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"issue":"7-8","key":"10.1016\/j.phrs.2019.03.002_bib0520","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/21678421.2017.1369125","article-title":"July 2017 ENCALS statement on edaravone","volume":"18","author":"Al-Chalabi","year":"2017","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"issue":"sup1","key":"10.1016\/j.phrs.2019.03.002_bib0525","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/21678421.2017.1353101","article-title":"Edaravone and its clinical development for amyotrophic lateral sclerosis","volume":"18","author":"Takei","year":"2017","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"issue":"10","key":"10.1016\/j.phrs.2019.03.002_bib0530","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S1474-4422(17)30290-9","article-title":"Edaravone for treatment of early-stage ALS - Authors\u2019 reply","volume":"16","author":"Akimoto","year":"2017","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.phrs.2019.03.002_bib0535","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Abe","year":"2017","journal-title":"Lancet Neurol."},{"issue":"42","key":"10.1016\/j.phrs.2019.03.002_bib0540","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1523\/JNEUROSCI.1092-08.2008","article-title":"Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration","volume":"28","author":"Poesen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.03.002_bib0545","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0550","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1515\/CCLM.2011.088","article-title":"The effect of apolipoprotein e (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer\u2019s disease","volume":"49","author":"Leoni","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"8","key":"10.1016\/j.phrs.2019.03.002_bib0555","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.neurobiolaging.2007.11.003","article-title":"APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer\u2019s disease","volume":"30","author":"Barabash","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0560","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/JAD-2010-1255","article-title":"Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia","volume":"19","author":"Reitz","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"44","key":"10.1016\/j.phrs.2019.03.002_bib0565","doi-asserted-by":"crossref","first-page":"30538","DOI":"10.1074\/jbc.M114.600833","article-title":"Amyloid-\u03b2 pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo","volume":"289","author":"Tai","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0570","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/302710","article-title":"The number of trait loci in late-onset Alzheimer disease","volume":"66","author":"Daw","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.002_bib0575","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.phrs.2019.03.002_bib0580","doi-asserted-by":"crossref","first-page":"e6501","DOI":"10.1371\/journal.pone.0006501","article-title":"Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer\u2019s disease","volume":"4","author":"Potkin","year":"2009","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.phrs.2019.03.002_bib0585","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.phrs.2019.03.002_bib0590","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"issue":"7000","key":"10.1016\/j.phrs.2019.03.002_bib0595","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer\u2019s disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"issue":"27","key":"10.1016\/j.phrs.2019.03.002_bib0600","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.2174\/1568026617666170607114232","article-title":"Oxidative stress, mitochondrial abnormalities and proteins deposition: multitarget approaches in Alzheimer\u2019s disease","volume":"17","author":"Giulia","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.phrs.2019.03.002_bib0605","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2018.03.010","article-title":"VDAC1, mitochondrial dysfunction, and Alzheimer\u2019s disease","volume":"131","author":"Shoshan-Barmatz","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.002_bib0610","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer\u2019s disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0615","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(01)00327-X","article-title":"The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer\u2019s disease","volume":"23","author":"Selley","year":"2002","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.phrs.2019.03.002_bib0620","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0197-4580(01)00340-2","article-title":"Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer\u2019s disease brain contribute to neuronal death","volume":"23","author":"Butterfield","year":"2002","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.phrs.2019.03.002_bib0625","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bbrc.2006.09.083","article-title":"Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse","volume":"350","author":"Nishida","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"48","key":"10.1016\/j.phrs.2019.03.002_bib0630","doi-asserted-by":"crossref","first-page":"33400","DOI":"10.1074\/jbc.M109.054056","article-title":"Depletion of vitamin e increases amyloid \u03b2 accumulation by decreasing its clearances from brain and blood in a mouse model of alzheimer disease","volume":"284","author":"Nishida","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2019.03.002_bib0635","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.002_bib0640","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.2353\/ajpath.2009.090417","article-title":"Phenolic Compounds Prevent Alzheimer\u2019s Pathology through Different Effects on the Amyloid-\u03b2 Aggregation Pathway","volume":"175","author":"Hamaguchi","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.002_bib0645","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.pbb.2010.06.009","article-title":"Neuroprotective effects of the polyphenolic antioxidant agent, Curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rat","volume":"96","author":"Ataie","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0650","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cbi.2008.05.003","article-title":"Antioxidant and radical scavenging properties of curcumin","volume":"174","author":"Ak","year":"2008","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0655","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","article-title":"Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease","volume":"28","author":"Baum","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.002_bib0660","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4103\/1673-5374.230303","article-title":"Use of curcumin in diagnosis, prevention, and treatment of Alzheimer&\u2019s disease","volume":"13","author":"Chen","year":"2018","journal-title":"Neural Regen. Res."},{"issue":"12","key":"10.1016\/j.phrs.2019.03.002_bib0665","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3390\/ijms18122504","article-title":"Role of vitamin e in the treatment of alzheimer\u2019s disease: evidence from animal models","volume":"18","author":"Gugliandolo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0670","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson\u2019s disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol. Brain"},{"issue":"Suppl 11","key":"10.1016\/j.phrs.2019.03.002_bib0675","article-title":"Motor fluctuations and dyskinesias in Parkinson\u2019s disease: clinical manifestations","volume":"20","author":"Jankovic","year":"2005","journal-title":"Mov. Disord."},{"issue":"9680","key":"10.1016\/j.phrs.2019.03.002_bib0680","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson\u2019s disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.phrs.2019.03.002_bib0685","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMcp043908","article-title":"Clinical practice. Diagnosis and initial management of Parkinson\u2019s disease","volume":"353","author":"Nutt","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.phrs.2019.03.002_bib0690","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1038\/emboj.2013.228","article-title":"Endonuclease G mediates \u03b1\u2010synuclein cytotoxicity during Parkinson\u2019s disease","volume":"32","author":"B\u00fcttner","year":"2013","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.phrs.2019.03.002_bib0695","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/genes8120377","article-title":"Mitochondria and \u03b1-Synuclein: Friends or Foes in the Pathogenesis of Parkinson\u2019s Disease?","volume":"8","author":"Faustini","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.phrs.2019.03.002_bib0700","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1326-4-49","article-title":"Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson\u2019s disease","volume":"4","author":"Falk","year":"2009","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.002_bib0705","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2011.03.088","article-title":"Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson\u2019s disease","volume":"496","author":"Falk","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2019.03.002_bib0710","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuroscience.2013.11.038","article-title":"Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson\u2019s disease","volume":"258","author":"Yue","year":"2014","journal-title":"Neuroscience"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819303317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819303317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:56:43Z","timestamp":1760911003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819303317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":142,"alternative-id":["S1043661819303317"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.03.002","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel function of VEGF-B as an antioxidant and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}